FDA Complaint Posted for Public Comment

The Food and Drug Administration (FDA) has opened a public comment period for a complaint, identified by docket number FDA-2026-H-2602-0001. While the full content of the complaint is not directly available for viewing, an attachment labeled 'Complaint' authored by CTP is provided. The comment period is scheduled to close on March 19, 2026.

Regulated entities, including drug manufacturers, food manufacturers, medical device makers, and pharmaceutical companies, should review the complaint once it becomes accessible and consider submitting comments by the deadline. Failure to participate in the comment period may result in the FDA proceeding without considering stakeholder input on the issues raised in the complaint.